We are live on ! Find out more
TA

Tamarack Advisers Portfolio holdings

AUM $2.12M
1-Year Est. Return 58.09%
This Fund
S&P 500
This Quarter Est. Return
+8.42%
1 Year Est. Return
-58.09%
3 Year Est. Return
-46.51%
5 Year Est. Return
+44.44%
10 Year Est. Return
–
AUM
$353M
AUM Growth
-$134M
Cap. Flow
-$160M
Cap. Flow %
-45.25%
Top 10 Hldgs %
53.01%
Holding
85
New
13
Increased
11
Reduced
25
Closed
34

Top Buys

Rank Stock Value
1
HSIC icon
Henry Schein
HSIC
+$15.5M
2
CI icon
Cigna
CI
+$8.74M
3
AHCO icon
AdaptHealth
AHCO
+$8.55M
4
VTRS icon
Viatris
VTRS
+$8.32M
5
UNH icon
UnitedHealth
UNH
+$7.97M

Top Sells

Rank Stock Value
1
LH icon
Labcorp
LH
+$19.6M
2
HOLX
Hologic
HOLX
+$18.4M
3
DGX icon
Quest Diagnostics
DGX
+$17.7M
4
LMNX
Luminex Corp
LMNX
+$15.3M
5
RDNT icon
RadNet
RDNT
+$12.1M

Sector Composition

Rank Sector Weight
1 Healthcare 86.67%
2 Consumer Staples 5.19%
3 Consumer Discretionary 1.58%
4 Technology 0.36%
5 Energy 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DMTK
26
DELISTED
DermTech, Inc. Common Stock
DMTK
$5.61M 1.59%
135,000
+51,000
+61% +$2.09M
CALY
27
Callaway Golf Company
CALY
$3.28B
$5.57M 1.58%
165,000
+84,000
+104% +$2.7M
INNV icon
28
InnovAge Holding
INNV
$1.56B
$3M 0.85%
+141,000
New +$3.23M
MSACU
29
DELISTED
Medicus Sciences Acquisition Corp. Unit
MSACU
$2.86M 0.81%
296,636
-303,364
-51% -$3.09M
CNC icon
30
Centene
CNC
$31.6B
$2.55M 0.72%
+35,000
New +$2.4M
ISEE
31
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$2.52M 0.71%
400,000
-175,000
-30% -$1.13M
PRGO icon
32
Perrigo
PRGO
$1.4B
$2.29M 0.65%
50,000
+25,000
+100% +$1.11M
DGX icon
33
Quest Diagnostics
DGX
$25.6B
$1.98M 0.56%
15,000
-135,000
-90% -$17.7M
OEF icon
34
PUT
iShares S&P 100 ETF
OEF
$19.8B
$1.59M 0.45%
5,000
+1,000
+25% +$190K
PLXS icon
35
Plexus
PLXS
$6.78B
$1.28M 0.36%
14,000
-96,000
-87% -$9M
CMIIU
36
DELISTED
CM Life Sciences II Inc. Unit
CMIIU
$673K 0.19%
50,000
-50,000
-50% -$666K
ABT icon
37
PUT
Abbott
ABT
$182B
$670K 0.19%
+1,000
New +$117K
BIO icon
38
Bio-Rad Laboratories Class A
BIO
$8.47B
$644K 0.18%
+1,000
New +$609K
HOLX
39
CALL
DELISTED
Hologic
HOLX
$568K 0.16%
+2,500
New +$167K
CERS icon
40
Cerus
CERS
$615M
$443K 0.13%
75,000
-75,000
-50% -$440K
SPY icon
41
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$781B
$328K 0.09%
3,500
+1,400
+67% +$584K
LH icon
42
Labcorp
LH
$24.7B
$276K 0.08%
1,164
-86,136
-99% -$19.6M
BSX icon
43
CALL
Boston Scientific
BSX
$67.6B
$258K 0.07%
2,000
+1,000
+100% +$42.1K
BMY icon
44
CALL
Bristol-Myers Squibb
BMY
$128B
$245K 0.07%
+2,500
New +$163K
ARKG icon
45
PUT
ARK Genomic Revolution ETF
ARKG
$1.54B
$225K 0.06%
1,500
-1,500
-50% -$128K
CTVA icon
46
CALL
Corteva
CTVA
$58.6B
$158K 0.04%
+1,500
New +$69.3K
PFE icon
47
CALL
Pfizer
PFE
$141B
$84K 0.02%
+3,500
New +$136K
GLD icon
48
CALL
SPDR Gold Trust
GLD
$132B
$70K 0.02%
5,000
-3,000
-38% -$510K
MSACW
49
DELISTED
Medicus Sciences Acquisition Corp. Warrant
MSACW
$67K 0.02%
+66,665
New +$52.8K
XLV icon
50
PUT
State Street Health Care Select Sector SPDR ETF
XLV
$42.2B
$24K 0.01%
+1,500
New +$184K
1
2
3 4

Similar funds

SCM
SevenOneSeven Capital Management Lancaster, Pennsylvania $2.17M AUM 8.67% 1-Year Est. Return
LBC
Lawrence B. Cohen $2.06M AUM 34.47% 1-Year Est. Return
ICM
ISZO Capital Management New York $2M AUM 35.61% 1-Year Est. Return
LCMP
Linse Capital Management PR San Juan, Puerto Rico $2.31M AUM
GIP
General Industrial Partners London, United Kingdom $2.57M AUM
STC
Sarah T. Connolly $1.11M AUM 24.13% 1-Year Est. Return
GC
Gilfoyle & Co San Francisco, California $671K AUM
DU
Delphia (USA) Toronto, Ontario, Canada $445K AUM 28.82% 1-Year Est. Return

Tamarack Advisers's Q2 2021 Portfolio in Review

As of Q2 2021, Tamarack Advisers held 85 positions worth $353M, down 28% from $488M the previous quarter. Its ten largest holdings account for 53% of the portfolio.

Tamarack Advisers withdrew a net $160M in Q2 2021, closing 34 positions and reducing 25 holdings. Its most notable exit was Hologic, an estimated $18.4M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 87% of assets, up from 85% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.

Against the trend, Tamarack Advisers opened a new position in Cigna worth $8.3M.

  • Tamarack Advisers's largest Q2 2021 buy was Cigna: 35,000 shares worth $8.3M.
  • Tamarack Advisers added most to Henry Schein in Q2 2021, an estimated $15.5M increase.
  • Tamarack Advisers's biggest Q2 2021 reduction was Labcorp, cutting an estimated $19.6M.
  • Tamarack Advisers fully exited Hologic in Q2 2021, selling an estimated $18.4M.
  • Tamarack Advisers's ten largest holdings make up 53% of its $353M portfolio in Q2 2021.
  • Tamarack Advisers opened 13 new positions and closed 34 in Q2 2021.
  • Tamarack Advisers's portfolio value fell 28% quarter-over-quarter to $353M.

Based on Tamarack Advisers's 13F filing for Q2 2021, filed 13 Aug 2021.